Nama's AI scorecard currently rates Intuitive Surgical Strong Buy (8.9 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is ISRG's P/E ratio?

Intuitive Surgical trades at a trailing price-to-earnings ratio of 41.8.

When does ISRG report earnings?

Intuitive Surgical's next scheduled report is on Jan 21, 2027. Analysts expect EPS of $2.95.

What is the ISRG price target?

The median analyst price target from 30 analysts is $488.00, with a range of $324.00 – $685.00.

Is ISRG Shariah compliant?

Nama's AAOIFI-style screen reads Intuitive Surgical as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.

Nama Insights

Intuitive Surgical (ISRG)

Healthcare · Medical Instruments Supplies · NASDAQ

S&P 500Nasdaq-100

Intuitive Surgical (ISRG) is a Healthcare company in the Medical Instruments Supplies industry. It has a market capitalization of $159.96B, a trailing price-to-earnings ratio of 41.8 and a free-cash-flow yield of 1.5%. Over the most recent reported fiscal year, revenue grew 20.5% and free cash flow per share grew 90.7%. Nama's AI scorecard rates it Strong Buy, 8.9 out of 10. On 12-month momentum it ranks in the trailing band of its market.

AI scorecard

Strong Buy · 8.9/10

The top band of the Fundamental Verdict (8.6–10). As of Nov 7, 2026.

Momentum

Trailing · -24.3% over 12 months ex. last

Bottom 20% of its market on the past year's move.

Shariah screen

Shariah Compliant

Passes our debt, cash and income screen; not a scholar's ruling.

Off its high

-26.5%

How far the last close sits under the highest price of the past five years.

Market cap	$159.96B
Trailing P/E	41.8
Price / book	10.0
Price / sales	13.8
FCF yield	1.5%
Dividend yield	—
Gross margin	67.2%
Operating margin	32.2%
Net margin	25.5%
Revenue growth (YoY)	+20.5%
Revenue growth (3-yr annual)	+17.4%
EPS growth (YoY)	+21.8%
FCF/share growth (YoY)	+90.7%
Beta	1.5
Exchange	NASDAQ
Sector	Healthcare
Industry	Medical Instruments Supplies

ISRG earnings

Next report: Jan 21, 2027 (Q4 2026, EPS estimate $2.95). Beat the EPS estimate in 4 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Oct 20, 2026	$3.00	$2.64	+13.6%	$3.05B
Q2 2026	Jul 16, 2026	$2.80	$2.50	+12.0%	$2.89B
Q1 2026	Apr 21, 2026	$2.50	$2.11	+18.5%	$2.77B
Q4 2025	Jan 22, 2026	$2.53	$2.27	+11.4%	$2.87B

ISRG analyst price target

Median target $488.00 from 30 analysts, ranging $324.00 – $685.00.

Medical Instruments Supplies peers

Ticker	Company	Market cap	P/E
BDX	Becton, Dickinson	$57.71B	16.1
MDLN	Medline	$52.17B	25.1
ALC	Alcon	$36.23B	23.0
RMD	ResMed	$33.10B	20.4
WST	West Pharmaceutical Services	$27.85B	43.5
SOLV	Solventum	$15.38B	12.8
BAX	Baxter International	$13.34B	13.3
COO	Cooper Companies	$11.86B	13.5

Explore live ISRG data on Nama Insights →

Recent Congressional trades

Intuitive Surgical trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Alan Armstrong	Senate	Buy	$1,001 - $15,000	Jul 21, 2026
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Feb 13, 2026
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Jan 12, 2026
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Dec 15, 2025
Josh Gottheimer	House	Sell	$1,001 - $15,000	Oct 15, 2025
Lisa McClain	House	Sell	$1,001 - $15,000	Aug 13, 2025
Lisa McClain	House	Buy	$1,001 - $15,000	Aug 13, 2025
Lisa McClain	House	Sell	$1,001 - $15,000	Aug 13, 2025
Lisa McClain	House	Buy	$1,001 - $15,000	Aug 13, 2025
Jefferson Shreve	House	Sell	$15,001 - $50,000	Jun 22, 2025
Jefferson Shreve	House	Buy	$15,001 - $50,000	Jun 22, 2025
Josh Gottheimer	House	Sell	$1,001 - $15,000	May 14, 2025

ISRG FAQ

Is ISRG a buy?: Nama's AI scorecard currently rates Intuitive Surgical Strong Buy (8.9 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is ISRG's P/E ratio?: Intuitive Surgical trades at a trailing price-to-earnings ratio of 41.8.
When does ISRG report earnings?: Intuitive Surgical's next scheduled report is on Jan 21, 2027. Analysts expect EPS of $2.95.
What is the ISRG price target?: The median analyst price target from 30 analysts is $488.00, with a range of $324.00 – $685.00.
Is ISRG Shariah compliant?: Nama's AAOIFI-style screen reads Intuitive Surgical as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.